Where Data Tells the Story
© Voronoi 2026. All rights reserved.
A snapshot of the world’s most valuable drugmakers as of Sept 19, 2025, ranked by market cap in USD billions. Eli Lilly leads the pack at $685B, followed by Johnson & Johnson ($419B) and AbbVie ($392B). The list spans 10 countries, with the U.S. dominating 11 of the top 20 spots.
Takeaway: The top three alone account for over 39% of the combined value of all 20 companies, underscoring the concentration of market power in a few mega‑players.
Quick Analysis: